Logo image
Back
First injection of ketamine among young injection drug users (IDUs) in three U.S. cities
Journal article   Open access   Peer reviewed

First injection of ketamine among young injection drug users (IDUs) in three U.S. cities

Stephen E Lankenau, Bill Sanders, Jennifer Jackson Bloom, Dodi Hathazi, Erica Alarcon, Stephanie Tortu and Michael C Clatts
Drug and alcohol dependence, v 87(2-3), pp 183-193
16 Mar 2007
DOI: https://doi.org/10.1016/j.drugalcdep.2006.08.015
PMID: 16979848
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1016/j.drugalcdep.2006.08.015View
Published, Version of Record (VoR) Open

Abstract

Substance Abuse, Intravenous - psychology Injections, Intravenous Humans Analgesics - administration & dosage Male Injections, Intramuscular Urban Population Needle Sharing - statistics & numerical data Ketamine - administration & dosage Socioeconomic Factors Sample Size Ethnic Groups Injections, Subcutaneous Adolescent Sexuality Adult Female Interviews as Topic Substance-Related Disorders - drug therapy
Ketamine, a dissociative anesthetic, has emerged as an increasingly common drug among subgroups of young injection drug users (IDUs) in cities across the United States. In-depth qualitative interviews were conducted with 213 young IDUs aged 16-28 years recruited in New York, New Orleans, and Los Angeles between 2004 and 2006. While some initiated injection drug use with ketamine, the drug was more frequently injected by IDUs with extensive polydrug using histories. IDUs initiating with ketamine commonly self-injected via an intramuscular mode of administration. The injection group provided crucial knowledge and material resources that enabled the injection event to occur, including ketamine, syringes, and injection skills. Injection paraphernalia was commonly shared during the first injection of ketamine, particularly vials of pharmaceutically-packaged liquid ketamine. Injection events infrequently occurred in a rave or club and more typically in a private home, which challenges ketamine's designation as a 'club' drug. The first injection of ketamine was a noteworthy event since it introduced a novel drug or new mode of administration to be further explored by some, or exposed others to a drug to be avoided in the future. Risk reduction messages directed towards young IDUs should be expanded to include ketamine.

Metrics

10 Record Views
44 citations in Web of Science
53 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Industry collaboration
Domestic collaboration
Web of Science research areas
Psychiatry
Substance Abuse
Logo image